| ID | Name | CAS |
MW (g/mol) |
| 71-041-7 |
Perfluorotetradecane
|
307-62-0 | 738.10 |
| 21-316-7 |
Scopoletin «beta»-D-glucopyranoside, TFA
|
| 738.34 |
| 27-867-0 |
20-Hydroxyprednisolone, MO TMS
|
| 738.38 |
| 72-794-1 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2,2,2-Trifluoroacetyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate
|
| 738.66 |
| 40-768-5 |
Mesoporphyrin-IX dimethyl ester, bis(trimethylsiloxy)silicon(IV) derivative
|
| 739.11 |
| 78-155-4 |
Epigallocatechin (6TMS)
|
| 739.35 |
| 30-882-9 |
3-Oxo-«alpha»-ionol, Gly, TFA
|
| 740.49 |
| 71-062-4 |
Silica-octaethylporphyrine complex, bis-OTMS
|
| 741.24 |
| 35-646-6 |
Triamcinolone, MO TMS
|
| 741.24 |
| 114-375-9 |
Butanoic acid, heptafluoro-, 4-[2-[(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)amino]-1-(2,2,3,3,4,4,4-heptafluoro-1-oxobutoxy)ethyl]phenyl ester
|
55538-87-9 | 741.25 |
| 44-827-5 |
Butanoic acid, heptafluoro-, 4-[2-[(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)amino]ethyl]-1,2-phenylene ester
|
55538-89-1 | 741.25 |
| 77-530-8 |
Cyclodecasiloxane, eicosamethyl-
|
18772-36-6 | 741.54 |
| 50-882-7 |
2-hydroxy-3-butenyl glucosinolate, TMS
|
| 742.42 |
| 16-433-3 |
B-Cortol TMS
|
17563-09-6 | 743.44 |
| 78-126-6 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate
|
| 744.79 |
| 67-811-7 |
13,25-dimethylhenpentacontane
|
| 745.42 |
| 15-380-3 |
13,23-Dimethylhenpentacontane
|
| 745.42 |
| 81-511-4 |
lead(2+) heptadecanoate
|
63399-94-0 | 746.10 |
| 50-956-5 |
N6-(cyclotetramethylene-tertbutylsilyl)-Adenosine, 2',3',5'-tris-O-TBDMS
|
| 750.32 |
| 11-144-9 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2,2,3,3,3-Pentafluoropropanoyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,3,3,3-pentafluoropropanoate
|
| 750.57 |
| 43-128-2 |
Bis(3,4-bis(phthalamido)phenyl) ether
|
52766-62-8 | 750.67 |
| 97-202-0 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-Methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,3,3,3-pentafluoropropanoate
|
| 750.74 |
| 73-402-4 |
1,1'-(5-Phenyl-1,1,3,3,5,5-hexamethyltrisiloxanyl)-ferrocene
|
| 751.15 |
| 116-793-3 |
Myricetin 6TMS
|
4067-68-9 | 751.32 |
| 37-889-5 |
Myricetin, hexakis(trimethylsilyl) ether
|
| 751.32 |
| 56-466-3 |
Prednisolone, MO TMS
|
| 751.38 |
| 39-186-3 |
(-)-Norepinephrine, N,O,O',O''-tetrakis(pentafluoropropionyl)-
|
| 753.24 |
| 31-100-5 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy-5«beta»-C29-dioic bile acid, methyl ester, TMS
|
| 753.28 |
| 113-895-3 |
4,5-Dihydroprednisolone, MO TMS
|
| 753.39 |
| 23-346-2 |
3«alpha»,7«beta»,14«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 14-959-2 |
3«alpha»,7«beta»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 37-834-5 |
3«alpha»,7«alpha»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 58-231-1 |
3«alpha»,5«beta»,7«beta»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 38-072-0 |
3«alpha»,7«alpha»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 48-572-4 |
3«alpha»,5«beta»,12«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 53-090-3 |
3«alpha»,5«beta»,7«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
| 753.40 |
| 51-615-2 |
1,10-Diiodoperfluorodecane
|
| 753.88 |
| 63-665-4 |
4-Oxo-«beta»-ionol, Gly, TFA
|
| 754.47 |
| 71-061-5 |
1,1'-Bis-[3-(p-biphenylyl)-1,1,3,3-tetramethyl disiloxanyl] ferrocene
|
| 755.03 |
| 35-718-6 |
Dexamethasone, 6-hydroxy, MO TMS
|
| 755.27 |
| 73-807-5 |
myo-Inositol, hexakis(trifluoroacetate)
|
| 756.20 |
| 72-663-6 |
2-Diethylaminoethyl-4-(4'-hydroxyphenoxy)-3',3,5-triiodophenylacetate,hydrochloride
|
96972-64-4 | 757.57 |
| 11-654-3 |
D-Sorbitol, hexakis(trifluoroacetate)
|
| 758.22 |
| 19-079-4 |
Dulcitol, hexakis(trifluoroacetate)
|
| 758.22 |
| 64-333-1 |
D-Mannitol, hexakis(trifluoroacetate)
|
| 758.22 |
| 98-893-3 |
Morphine, sulfate (pentahydrate)
|
| 758.83 |
| 47-030-6 |
13,23,27-trimethylhenpentacontane
|
| 759.45 |
| 48-072-9 |
Tetrapentacontane
|
5856-66-6 | 759.45 |
| 22-815-2 |
13,21,25-trimethylhenpentacontane
|
| 759.45 |
| 24-696-3 |
1-Caffeoyl quinic acid, TMS
|
| 761.36 |
| 46-802-0 |
4-Caffeoyl quinic acid, TMS
|
| 761.36 |
| 47-340-2 |
2-[2-[2-[2-[2-[2-[2-[2-(2,2,3,3,4,4,4-Heptafluorobutanoyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,3,3,4,4,4-heptafluorobutanoate
|
| 762.48 |
| 71-065-1 |
Benzene-hexa-n-hexanoate
|
65201-69-6 | 762.97 |
| 15-057-2 |
Prednisone, MO TMS
|
| 764.38 |
| 66-007-1 |
Digitoxin
|
71-63-6 | 764.94 |
| 22-525-4 |
7«alpha»,12«alpha»,26-trihydroxy,3-oxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
| 765.37 |
| 61-136-3 |
myo-Inositol phosphate, heptakis-TMS
|
| 765.40 |
| 71-723-0 |
myo-Inositol-1-phosphate, 7TMS
|
| 765.40 |
| 76-825-2 |
myo-Inositol-1-phosphate, TMS
|
| 765.40 |
| 76-824-3 |
myo-Inositol phosphate, 7TMS
|
| 765.40 |
| 36-372-9 |
Noradrenaline, DTFMB-TBDMS
|
| 766.09 |
| 114-137-3 |
Adrenaline, DTFMB-TBDMS
|
| 766.09 |
| 26-945-4 |
4,5-Dihydroprednisone, MO TMS
|
| 766.39 |
| 33-673-8 |
(.+/-.)-Epinephrine, N,O,O',O''-tetrakis(pentafluoropropionyl)-
|
| 767.27 |
| 20-489-7 |
(-)-Epinephrine, N,O,O',O''-tetrakis(pentafluoropropionyl)-
|
| 767.27 |
| 124-704-2 |
Caramiphen ethanedisulfonate
|
| 769.02 |
| 119-361-9 |
1-Phenylcyclopentanecarboxylic acid, 2-diethyl-aminoethyl ester, 1,2-ethanedisulfonate
|
| 769.02 |
| 38-435-7 |
3«alpha»,7«alpha»,12«alpha»,24-tetrahydroxy-5««beta»'»-C27-bile acid, methyl ester, TMS
|
| 769.40 |
| 45-713-0 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-C27-bile acid, methyl ester, TMS
|
| 769.40 |
| 46-796-8 |
3«alpha»,7«alpha»,12«alpha»,24(«epsilon»)-tetrahydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
| 769.40 |
| 18-247-8 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
| 769.40 |
| 55-439-4 |
benzyl glucosinolate, TMS
|
| 770.34 |
| 123-542-3 |
Vomifoliol 1A, Gly, TFA
|
| 770.47 |
| 116-157-9 |
Vomifoliol 2A, Gly, TFA
|
| 770.47 |
| 24-045-5 |
1-Deoxy-1-(methylamino)-D-galactitol, N,O,O,O,O,O-hexa(trifluoroacetyl)-
|
| 771.26 |
| 77-493-0 |
Acetic acid, [3,5-diiodo-4-(3-iodo-4-methoxyphnoxy) phenyl]-, 2-diethylaminoethyl ester, hydrochloride
|
57-65-8 | 771.59 |
| 31-176-2 |
1,15-Di(1-phenylpropyl)-2,2,4,4,6,6,8,8,10,10,12,12,14,14-tetradecamethyl-1,3,5,7,9,11,13,15-octaoxa-2,4,6,8,10,12,14-heptasilapentadecane
|
| 773.44 |
| 57-827-1 |
13,21-Dimethyltripentacontane
|
| 773.48 |
| 74-609-4 |
Aluminum palmitate
|
| 774.10 |
| 42-792-6 |
lead distearate
|
1072-35-1 | 774.10 |
| 74-870-4 |
Bis(diphenoxyphosphoryloxy)alumanyl diphenyl phosphate
|
| 774.52 |
| 115-072-4 |
Basic lead carbonate
|
1319-46-6 | 775.60 |
| 64-261-1 |
2,2'-((1,8-Dihydroxy-3,6-disulfo-2,7-naphthylene)bis(azo)), dibenzene arsonic acid
|
1668-00-4 | 776.37 |
| 52-660-1 |
Aucubin, hexakis(trimethylsilyl) ether
|
| 779.42 |
| 104-631-5 |
Digoxin (L1=41,8mg/mL, L2=68,2mg/mL, Z=40,1mg/mL)
|
| 780.95 |
| 71-073-2 |
Estradiol monobenzoate
|
| 781.03 |
| 15-516-2 |
2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2,2,2-Trifluoroacetyl)oxyethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate
|
| 782.71 |
| 124-487-4 |
24-Hydroxy-trihydroxycoprostanic acid, Me-TMS, isomer 1
|
| 783.43 |
| 118-341-2 |
24-Hydroxy-trihydroxycoprostanic acid, Me-TMS, isomer 2
|
| 783.43 |
| 25-996-9 |
2-phenylethylglucosinolate, TMS
|
| 784.36 |
| 77-468-8 |
DOPA, HFIP-PFP
|
| 785.26 |
| 63-337-8 |
DL-Metanephrine, N,O,O'-tris(heptafluorobutyryl)-
|
| 785.30 |
| 78-289-6 |
Hexakis(pentafluoroethyl)benzene
|
17480-15-8 | 786.14 |
| 58-779-4 |
Triamcinolone, 20-hydroxy, MO TMS
|
| 786.40 |
| 27-232-4 |
Codeine, sulfate (pentahydrate)
|
| 786.88 |
| 17-877-0 |
3-Caffeoyl quinic acid, TMS
|
| 787.40 |
| 76-709-1 |
Caffeoylquinic acid, 5-trans-, 6TMS
|
| 787.40 |
| 124-212-8 |
trans-4-O-Caffeoyl-D-quinic acid, hexakis-TMS
|
| 787.40 |
| 117-119-0 |
Caffeoylquinic acid, 4-trans-, 6TMS
|
| 787.40 |
| 76-710-9 |
Caffeoylquinic acid, 3-trans-, 6TMS
|
| 787.40 |
|
« Previous Results
Next Results »
|